Future of the CFO: From Number Cruncher to Value Driver
View the high resolution of this infographic by clicking here.
In today’s fast-paced business landscape, a company’s chief financial officer (CFO) is more integral to operations than ever. In fact, about 41% of CFOs spend the majority of their time on non-finance related activities, fueling data-driven decisions across the business.
The only problem? Leaders outside of finance still see CFOs contributing the most value in traditional finance areas, such as accounting and controlling.
Today’s infographic from Raconteur explores the expanding scope of CFO responsibilities, as well as the perception gap between CFOs and non-finance leaders when it comes to the former’s primary value-driving activities.
The CFO’s Expanding Role
Traditionally, the CFO was focused on financial reporting and issues such as compliance, accounts, and taxation. However, the scope of a CFO’s duties has increased dramatically in recent years. Thanks to technological advances, CFOs are now able to access massive amounts of data on their organization’s operational and financial performance.
“This puts the finance function at the heart or, arguably, the mind of the business from the outset, with many now being crowned as the ‘stewards’ of the long-term enterprise vision.”
—Robin Bryson, Interim CFO at Impero Software
Armed with data, CFOs can help predict headwinds, forecast performance, and make informed decisions across departments. In a global survey, McKinsey asked finance leaders about the breadth of their responsibilities. Of the CFOs who said they spend they a majority of their time on non-finance tasks, here’s where their attention is focused:
|Activity||% of CFOs Focused on Activity|
|Big data and analytics||20%|
|Other (e.g. risk management)||5%|
However, other business leaders remain in the dark about this broader role.
While the CFO’s job description has evolved considerably, outside perceptions of it have not. In a survey of both CFOs and non-finance leaders, there is a clear difference of opinion with regards to where financial leaders create the most value:
|Areas in which CFOs have created the most financial value||% of CFOs who agree||% of others who agree|
|Traditional finance roles||33%||47%|
|Speciality finance roles||30%||27%|
|Cost and productivity management||26%||42%|
|Support for digital capabilities and advanced analytics||15%||10%|
|Mergers and acquisitions (including post-merger integration)||14%||23%|
|Pricing of products and/or services||10%||8%|
|Management of activist investors||3%||3%|
CFOs see their largest contributions in the areas of performance management and strategic leadership, while others still consider the CFO’s value to be derived primarily from traditional finance and cost/productivity management.
How can CFOs demonstrate their increased responsibility to leaders outside of the finance realm?
Closing the Gap
According to McKinsey, CFOs can demonstrate their expanded role in three main ways:
1. Actively head up transformations.
While CFOs are already playing a role in transformations, non-finance leaders are less likely to perceive them as making strategic contributions. CFOs also tend to initiate the most transformations in the finance function alone.
To change perceptions, CFOs can lead enterprise-wide transformations, and communicate their strategic value through activities like high-level goal setting.
2. Lead the charge towards digitization and automation.
Few organizations have initiated the shift in a substantial way, with only ⅓ of finance respondents saying their companies digitized or automated more than 25% of their work in the last year.
However, the payoff is well worth the effort. Among those that have undertaken this level of change, 70% reported modest to substantial returns on investment.
3. Develop talent and capabilities across the organization.
CFOs have begun increasing their value through talent-building, but there is still a significant amount of room for further growth.
For example, CFOs can build capabilities during transformations, teach financial topics to non-finance leaders, and develop top talent across the organization.
Through these various strategies, CFOs can foster collaboration and understanding between departments—and succeed in their broader roles.
Visualizing the World’s Biggest Pharmaceutical Companies
The world’s biggest pharmaceutical companies are worth $4.1 trillion. Here we map the top 100 companies based on their market cap value.
Who are the World’s Biggest Pharmaceutical Companies?
Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.
However, it’s likely no surprise that the pandemic has also been great for many healthcare businesses. In fact, in 2020 alone, the world’s 50 largest pharmaceutical companies still combined for a whopping $851 billion in revenues.
In this graphic, using data from Companies Market Cap, we list the largest pharmaceutical companies in the world by market capitalization. It’s worth noting this list also includes healthcare companies that work closely with pharmaceuticals, including biotech, pharmaceutical retailers, clinical laboratories, etc.
Editor’s Note: A previous version of this graphic was missing some key companies such as GSK and AbbVie. They were unfortunately not included in the original source and we are now working to make sure there were no other smaller omissions. Thanks to all that sent in corrections.
The Pharmaceutical Leaders
To start, here are the top five biggest pharmaceutical companies in the world at the moment by market capitalization:
1. Johnson & Johnson
The pharmaceutical and consumer goods giant is worth $428.7 billion in market cap. They developed the third vaccine authorized for use in the U.S. and were named among the TIME100 Most Influential Companies List in 2021.
The Swiss pharmaceutical giant is at the forefront of oncology, immunology, infectious diseases, ophthalmology, and neuroscience. In 2019, Roche’s pharma segment sales rose by a healthy 16% to $53 billion.
Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. The company has recently gained momentum, especially in the past quarter, with Q2’2021 revenues of $19.0 billion, reflecting a 86% operational growth from 2020.
4. Eli Lilly
Eli Lilly has taken a significant step towards establishing itself as a pharmaceutical industry leader. Having a market cap value of $125 billion in 2019, Eli Lilly has jumped to a current value of $214.9 billion, a significant growth of 72%.
The second-biggest pharmaceutical company out of Switzerland, Novartis has been the face of the pharma industry for about 25 years. The primary manufacturer for the most recognizable drugs on the market pulled in a revenue of over $48 billion in 2020, a 3% increase compared to 2019.
Here’s how all the biggest pharmaceutical companies in the world stack up against each other:
|Company Rank||Company Name||Market Cap Value||Country|
|1||Johnson & Johnson|
|$428.66 B||🇺🇸 USA|
|$320.41 B||🇨🇭 Switzerland|
|$219.39 B||🇺🇸 USA|
|$208.99 B||🇺🇸 USA|
|$207.70 B||🇨🇭 Switzerland|
|$202.60 B||🇺🇸 USA|
|$191.67 B||🇺🇸 USA|
|$187.83 B||🇩🇰 Denmark|
|$152.28 B||🇬🇧 UK|
|$145.80 B||🇺🇸 USA|
|$136.50 B||🇺🇸 USA|
|$130.37 B||🇫🇷 France|
|$110.49 B||🇺🇸 USA|
|$104.30 B||🇬🇧 UK|
|$103.10 B||🇦🇺 Australia|
|$83.62 B||🇺🇸 USA|
|$83.25 B||🇺🇸 USA|
|$80.61 B||🇩🇪 Germany|
|$59.43 B||🇩🇪 Germany|
|20||Jiangsu Hengrui Medicine |
|$58.51 B||🇨🇳 China|
|$55.83 B||🇺🇸 USA|
|$55.00 B||🇺🇸 USA|
|$54.23 B||🇩🇪 Germany|
|$52.67 B||🇯🇵 Japan|
|$52.16 B||🇨🇭 Switzerland|
|26||Walgreens Boots Alliance|
|$45.05 B||🇺🇸 USA|
|$33.80 B||🇰🇷 S. Korea|
|$33.42 B||🇯🇵 Japan|
|$31.65 B||🇨🇳 China|
|$31.20 B||🇯🇵 Japan|
|$26.59 B||🇺🇸 USA|
|32||Hansoh Pharma |
|$26.00 B||🇨🇳 China|
|$25.97 B||🇺🇸 USA|
|34||Otsuka Holdings |
|$23.15 B||🇯🇵 Japan|
|35||Horizon Therapeutics |
|$21.13 B||🇮🇪 Ireland|
|36||Alnylam Pharmaceuticals |
|$20.42 B||🇺🇸 USA|
|$18.85 B||🇯🇵 Japan|
|$18.74 B||🇺🇸 USA|
|$18.48 B||🇭🇰 Hong Kong|
|$17.25 B||🇺🇸 USA|
|$16.26 B||🇺🇸 USA|
|$16.03 B||🇳🇱 Netherlands|
|$15.29 B||🇯🇵 Japan|
|$11.88 B||🇮🇳 India|
|45||Teva Pharmaceutical Industries|
|$11.21 B||🇮🇱 Israel|
|46||Ono Pharmaceutical |
|$11.12 B||🇯🇵 Japan|
|$11.09 B||🇮🇪 Ireland|
|48||Bausch Health |
|$10.47 B||🇨🇦 Canada|
|$10.42 B||🇨🇭 Switzerland|
|$10.33 B||🇩🇪 Germany|
|51||Hualan Biological Engineering|
|$10.31 B||🇨🇳 China|
|$9.49 B||🇨🇭 Switzerland|
|53||Neurocrine Biosciences |
|$9.45 B||🇺🇸 USA|
|$9.42 B||🇨🇳 China|
|55||BridgeBio Pharma |
|$8.89 B||🇺🇸 USA|
|56||Cadila Healthcare |
|$8.59 B||🇮🇳 India|
|57||Sumitomo Dainippon Pharma |
|$8.16 B||🇯🇵 Japan|
|$7.89 B||🇨🇦 Canada|
|59||Ascendis Pharma |
|$7.51 B||🇩🇰 Denmark|
|$7.19 B||🇩🇪 Germany|
|61||Lupin Limited |
|$7.04 B||🇮🇳 India|
|62||Gland Pharma |
|$7.01 B||🇮🇳 India|
|$6.95 B||🇺🇸 USA|
|64||GW Pharmaceuticals |
|$6.81 B||🇬🇧 UK|
|$6.78 B||🇯🇵 Japan|
|66||Torrent Pharmaceuticals |
|$6.61 B||🇮🇳 India|
|$6.43 B||🇮🇳 India|
|$6.32 B||🇯🇵 Japan|
|69||Sarepta Therapeutics |
|$6.25 B||🇺🇸 USA|
|$6.21 B||🇮🇪 Ireland|
|$6.11 B||🇫🇮 Finland|
|$6.04 B||🇩🇰 Denmark|
|$5.87 B||🇨🇦 Canada|
|74||Adaptive Biotechnologies |
|$5.69 B||🇺🇸 USA|
|75||Intellia Therapeutics |
|$5.62 B||🇺🇸 USA|
|76||Santen Pharmaceutical |
|$5.49 B||🇯🇵 Japan|
|$5.46 B||🇯🇵 Japan|
|78||Beam Therapeutics |
|$5.43 B||🇺🇸 USA|
|79||Reata Pharmaceuticals |
|$5.15 B||🇺🇸 USA|
|80||Swedish Orphan Biovitrum|
|$5.13 B||🇸🇪 Sweden|
|81||BB Biotech |
|$5.08 B||🇨🇭 Switzerland|
|82||Alkem Laboratories |
|$5.00 B||🇮🇳 India|
|$4.69 B||🇮🇳 India|
|84||Laurus Labs |
|$4.44 B||🇮🇳 India|
|85||Taisho Pharmaceutical |
|$4.39 B||🇯🇵 Japan|
|86||Hanmi Pharmaceutical |
|$4.22 B||🇰🇷 S. Korea|
|$3.87 B||🇮🇪 Ireland|
|$3.71 B||🇺🇸 USA|
|$3.65 B||🇰🇷 S. Korea|
|$3.55 B||🇺🇸 USA|
|91||Ipca Laboratories |
|$3.41 B||🇮🇳 India|
|92||Nektar Therapeutics |
|$3.02 B||🇺🇸 USA|
|93||BioCryst Pharmaceuticals |
|$3.01 B||🇺🇸 USA|
|$2.96 B||🇺🇸 USA|
|$2.84 B||🇺🇸 USA|
|96||Rocket Pharmaceuticals |
|$2.74 B||🇺🇸 USA|
|97||Axsome Therapeutics |
|$2.65 B||🇺🇸 USA|
|98||Natco Pharma |
|$2.63 B||🇮🇳 India|
|$2.59 B||🇮🇳 India|
|100||Editas Medicine |
|$2.54 B||🇺🇸 USA|
World’s Largest Pharmaceutical Exporters and Importers
According to the World Trade Organization (WTO), these countries exported the most number of pharmaceuticals in the year 2019:
|Rank||Country||Export Value (US$B)|
In contrast, here are the biggest importers over the same period.
|Rank||Country||Import Value (US$B)|
This position is hardly surprising for the U.S., where six of the world’s top 10 pharmaceutical companies are headquartered. The country also captures 45% of the global market.
The Future of Pharmaceutical Companies
If the response to the COVID-19 pandemic has taught us anything, it is that in building a patient-centered future, the pharmaceutical industry plays a key role. It has to constantly find new ways to customize medicines while researching and developing new tools and drugs.
By embracing disruptive technologies like 3D printed drugs, artificial intelligence guided therapies, and preventive medicine while working with regulatory agencies, the pharmaceutical companies will benefit from having a digital revolution.
Furthermore, emerging markets will have a more significant say in the global pharmaceutical market in the coming years. Even though ‘big pharma’ will keep raking in the massive profits they do every year, their reliance on countries like Brazil and India for research and drug production will significantly impact the years to come.
Mapping The Biggest Companies By Market Cap in 60 Countries
Tech, finance or energy giant? We mapped the biggest companies by market cap and industry.
The Biggest Companies By Market Cap in 60 Countries
Tech giants are increasingly making up more of the Fortune 500, but the world’s biggest companies by market cap aren’t so cut and dry.
Despite accounting for the largest market caps worldwide—with trillion-dollar companies like Apple and contenders including Tencent and Samsung—tech wealth is largely concentrated in just a handful of countries.
So what are the biggest companies in each country? We mapped the largest company by market cap across 60 countries in August 2021 using market data from CompaniesMarketCap, TradingView, and MarketScreener.
What are the Largest Companies in the World?
The world has 60+ stock exchanges, and each one has a top company. We looked at the largest local company, since many of the world’s largest firms trade on multiple exchanges, and converted market cap to USD.
|Country||Company||Industry||Market Cap (August 2021)|
|Saudi Arabia||Saudi Aramco||Energy||$1.9T|
|Belgium||Anheuser-Busch Inbev||Consumer Staples||$122.7B|
|Indonesia||Bank Cental Asia||Financials||$54.8B|
|Philippines||SM Investments||Consumer Cyclical||$22.9B|
|Kuwait||Kuwait Finance House||Financials||$21.9B|
|Czech Republic||ÄŒEZ Group||Energy||$15.8B|
|Poland||PKO Bank Polski||Financials||$12.6B|
|Bahrain||Ahli United Bank||Financials||$8.6B|
|Egypt||Commercial International Bank||Financials||$5.9B|
Many are former monopolies or massive conglomerates that have grown in the public space, such as South Africa’s Naspers and India’s Reliance Industries.
Others are local subsidiaries of foreign corporations, including Mexico’s Walmex, Chile’s Enel and Turkey’s QNB Finansbank.
But even more noticeable is the economic discrepancy. Apple and Saudi Aramco are worth trillions of dollars, while the smallest companies we tracked—including Panama’s Copa Group and Oman’s Bank Muscat—are worth less than $5 billion.
Finance and Tech Dominate The Biggest Companies By Market Cap
Across the board, the largest companies were able to accumulate wealth and value.
Some are newer to the top thanks to recent success. Canada’s Shopify has become one of the world’s largest e-commerce providers, and the UK’s AstraZeneca developed one of the world’s COVID-19 vaccines.
But the reality is most companies here are old guards that grew on existing resources, or in the case of banks, accumulated wealth.
|Industry||Biggest Companies by Country|
Banks were the most commonly found at the top of each country’s stock market. Closely behind were oil and gas giants, mining companies, and former state-owned corporations that drove most of a country’s wealth generation.
But as more economies develop and catch up to Western economies (where tech is dominant), newer innovative companies will likely put up a fight for each country’s top company crown.
Green3 weeks ago
The World’s 25 Largest Lakes, Side by Side
Economy2 weeks ago
The 20 Fastest Growing Jobs in the Next Decade
Misc2 weeks ago
All World Languages in One Visualization
Markets1 week ago
Mapping The Biggest Companies By Market Cap in 60 Countries
Misc3 weeks ago
Razor Thin: A New Perspective on Earth’s Atmosphere
Healthcare1 week ago
Visualizing the World’s Biggest Pharmaceutical Companies
Misc3 weeks ago
9/11 Timeline: Three Hours That Changed Everything
Datastream4 weeks ago
Ranked: The World’s Fastest Growing Brands in 2021